Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Adagio Medical Holdings, Inc. (ADGM)

$0.48 -1.63% NASDAQ: ADGM · 15-min delayed
  • LAGUNA HILLS, California
  • Public · NASDAQ: ADGM
  • 41 employees
$16.1MMarket cap
$0Revenue · FY2025
-$25.1MNet income
41Employees
ADGMNASDAQ
2024IPO

About Adagio Medical Holdings, Inc.

Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$0
Net income
-$25.1M
Total assets
$43.3M
Market cap
$16.1M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$0
Cost of revenue
$684.0K
Operating income
-$21.9M
Income tax
$0
Net income
-$25.1M
EPS (basic)
$-1.51
EPS (diluted)
$-1.51

Balance sheet

Total assets
$43.3M
Current assets
$20.1M
Total liabilities
$30.9M
Current liabilities
$8.2M
Shareholders’ equity
$12.4M

Cash flow

Operating cash flow
-$19.0M
Investing cash flow
-$374.0K
Financing cash flow
$16.1M
Net cash flow
-$3.3M

Statements via Polygon.io (SEC filings)

NASDAQ: ADGM
$0.48 -1.63%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.44 $2.36

52-week range

Market cap
$16.1M
EPS (diluted)
$-1.51
Shares outstanding
33.5M
Open
Day range
Prev close
Volume
IPO date
Aug 1, 2024

Adagio Medical Holdings, Inc. (ADGM) Stock Price

  • Reported a net loss of $25.1M in FY2025.
  • Trading 80% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Adagio Medical Holdings, Inc..

Write a review
Newsroom

News about Adagio Medical Holdings, Inc.

News & sentiment via Polygon.io

FAQ

Adagio Medical Holdings, Inc.: frequently asked questions

Is Adagio Medical Holdings, Inc. an American company?

Adagio Medical Holdings, Inc. is a US-based company headquartered in Laguna Hills, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Adagio Medical Holdings, Inc. headquartered?

Adagio Medical Holdings, Inc. is headquartered in Laguna Hills, California, United States.

Is Adagio Medical Holdings, Inc. publicly traded?

Yes — Adagio Medical Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol ADGM on the NASDAQ.

What does Adagio Medical Holdings, Inc. do?

Adagio Medical Holdings, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →